InVivo Therapeutics Holdings Corp. (NVIV) Declined -7.45% or -0.54 To Price $6.71 On Wednesday

InVivo Therapeutics Holdings Corp. (NVIV) declined -7.45% or -0.54 to $6.71. It is around 58892 shares traded, which is 30.03% compare to the average total volume 196142. The market cap of NVIV is $10.50 million. The year to date change is -812.93%. The 52 week price range is from $6.16 to $96.25. Price of NVIV have changed 4.02% during last week. It have changed -11.59% over last month, -56.39% over last 3 months, -65.06% over last 6 months and -86.19% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NVIV is 8.22. It is 22.50% above current price. The 200-day Moving Averages for NVIV is 20.30. It is 202.53% above current price. The 52-week High is 96.25. It is 1334.43% from the current price. The 52-week Low is 6.16. It is -8.20% from current price.

There are some statistics of NVIV. It is has market cap $10.50 million. The share outstanding is 1.57 million. The average volume is 196142. It has 39.02M cash and 2.03M in debt. The percent of top 15 Institution holding is 0.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NVIV is -155.69%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NVIV is -119.02%.


Share this post